How pathogen-derived cysteine proteases modulate host immune responses

Advances in Experimental Medicine and Biology

Volumn 712, Issue , 2011, Pages 192-207

  Donnelly, Sheila ^a   Dalton, John P ^b   Robinson, Mark W ^a  

^a UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN L; CATHEPSIN L1; CD14 ANTIGEN; CHEMOKINE; COMPLEMENT; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C3B; COMPLEMENT COMPONENT C5; COMPLEMENT COMPONENT C5A; CYSTEINE PROTEINASE; CYTOKINE; CYTOKINE RECEPTOR; IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN D; IMMUNOGLOBULIN E; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 8; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ARTICLE; CELLULAR IMMUNITY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME MECHANISM; GENE EXPRESSION REGULATION; HOST PATHOGEN INTERACTION; HUMAN; IMMUNE RESPONSE; IMMUNE RESPONSE GENE; IMMUNOMODULATION; INNATE IMMUNITY; INTERLEUKIN 12 GENE; MOLECULAR RECOGNITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TH1 CELL; TH2 CELL; UBIQUITINATION; IMMUNITY; IMMUNOLOGY; REVIEW;

ADAPTIVE IMMUNITY; CYSTEINE PROTEASES; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY; IMMUNITY, INNATE; IMMUNOMODULATION;

EID: 80053332052     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4419-8414-2_12     Document Type: Article

References (115)

1. Colbert JD, Matthews SP, Miller G et al. Diverse regulatory roles for lysosomal proteases in the immune response. Eur J Immunol 2009; 39:2955-2965
2. Bird PI, Trapani JA, Villadangos JA. Endolysosomal proteases and their inhibitors in immunity. Nat Rev Immunol 2009; 9:871-882
3. Robinson MW, Menon R, Donnelly SM et al. An integrated transcriptomics and proteomics analysis of the secretome of the helminth pathogen Fasciola hepatica: proteins associated with invasion and infection of the mammalian host. Mol Cell Proteomics 2009; 8:1891-1907
4. Robinson MW, Dalton JP, Donnelly S. Helminth pathogen cathepsin proteases: it's a family affair. Trends Biochem Sci 2008; 33:601-608
5. McKerrow JH, Caffrey C, Kelly B et al. Proteases in parasitic diseases. Annu Rev Pathol 2006; 1:497-536
6. Imamura T. The role of gingipains in the pathogenesis ofperiodontal disease. J Periodontol 2003; 74:111-118
7. Onoe T, Hoover CI, Nakayama K et al. Identification of Porphyromonas gingivalis prefimbrilin possessing a long leader peptide: possible involvement of trypsin-like protease in fimbrilin maturation. Microb Pathog 1995; 19:351-364
8. Maliar T, Balaz S, Tandlich R et al. Viral proteinases-possible targets of antiviral drugs. Acta Virol 2002; 46:131-140
9. Harcourt BH, Jukneliene D, Kanjanahaluethai A et al. Identification of severe acute respiratory syndrome coronavirus replicase products and characterization of papain-like protease activity. Virol 2004; 78:13600-13612
10. EdelmannMJ, KesslerBM. Ubiquitin and ubiquitin-like specific proteases targeted by Infectious pathogens: Emerging patterns and molecular principles. Biochim Biophys Acta 2008; 1782:809-816
11. Alexander J, Bryson K. T helper (h) 1/Th2 and Leishmania: paradox rather than paradigm. Immunol Lett 2005; 99:17-23
12. Maekawa Y, Himeno K, Katunuma N. Cathepsin B-inhibitor promotes the development of Th1 type protective T-cells in mice infected with Leishmania major. J Med Invest 1997; 44:33-39
13. Maekawa Y, Himeno K, Ishikawa H et al. Switch of CD4+ T-cell differentiation from Th2 to Th1 by treatment with cathepsin B inhibitor in experimental leishmaniasis. J Immunol 1998; 161:2120-2127
14. Denise H, McNeil K, Brooks DR et al. Expression of multiple CPB genes encoding cysteine proteases is required for Leishmania mexicana virulence in vivo. Infect Immun 2003; 71:3190-3195
15. Pollock KG, McNeil KS, Mottram JC et al. The Leishmania mexicana cysteine protease, CPB2.8, induces potent Th2 responses. J Immunol 2003; 170:1746-1753
16. Giordanengo L, Guinazu N, Stempin C et al. Cruzipain, a major Trypanosoma cruzi antigen, conditions the host immune response in favor of parasite. Eur J Immunol 2002; 32:1003-1011
17. Sokol CL, Barton GM, Farr AG et al. A mechanism for the initiation of allergen-induced T helper type 2 responses. Nat Immunol 2008; 9:310-318
18. Sokol CL, Chu NQ, Yu S et al. Basophils function as antigen-presenting cells for an allergen-induced T helper type 2 response. Nat Immunol 2009; 10:713-720
19. Phillips C, Coward WR, Pritchard DI et al. Basophils express a type 2 cytokine profile on exposure to proteases from helminths and house dust mites. J Leukoc Biol 2003; 73:165-171
20. Brady MT, O'Neill SM, Dalton JP et al. Fasciola hepatica suppresses a protective Th1 response against Bordetella pertussis. Infect Immun 1999; 67:5372-5378
21. O'Neill SM, Brady MT, Callanan JJ et al. Fasciola hepatica infection downregulates Th1 responses in mice. Parasite Immunol 2000; 22:147-155
22. O'Neill SM, Mills KH, Dalton JP. Fasciola hepatica cathepsin L cysteine proteinase suppresses Bordetella pertussis-specific interferon-gammaproduction in vivo. Parasite Immunol 2001; 23:541-547
23. Pearce EJ, MacDonald AS. The immunobiology of schistosomiasis. Nat Rev Immunol. 2002; 2:499-511
24. Sung CK, Dresden MH. Cysteinyl proteinases of Schistosoma mansoni eggs: purification and partial characterization. J Parasitol. 1986; 72: 891-900
25. Donnelly S, O'Neill SM, Stack CM et al. Helminth cysteine proteases inhibit TRIF-dependent activation of macrophages via degradation of TLR3. J Biol Chem. 2010; 285:3383-3392
26. Dowling DJ, Hamilton CM, Donnelly S et al. Major secretory antigens of the helminth Fasciola hepatica activate a suppressive dendritic cell phenotype that attenuates Th17 cells but fails to activate Th2 immune responses. Infect Immun 2010; 78:793-801
27. Potempa J, Pike RN. Corruption of innate immunity by bacterial proteases. J Innate Immun 2009; 1:70-87
28. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell 2006; 124:783-801
29. Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 2010; 11:373-384
30. Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol 4:499-511
31. O'Neill LA, Bowie AG. The family offive: TIR-domain-containing adaptors in Toll-like receptor signalling. Nat Rev Immunol 2007; 7:353-364
32. Kawai T, Akira S. Signaling to NF-kappaB by Toll-like receptors. Trends Mol Med 2007; 13:460-469
33. Slots J, Ting M. Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in human periodontal disease: occurrence and treatment. Periodontol 1999; 20:82-121
34. Holt SC, Kesavalu L, Walker S et al. Virulence factors of Porphyromonas gingivalis. Periodontol 1999; 20:168-238
35. Gioannini TL, Weiss JP. Regulation of interactions of Gram-negative bacterial endotoxins with mammalian cells. Immunol Res 2007; 39:249-260
36. Sugawara S, Nemoto E, Tada H et al. Proteolysis of human monocyte CD14 by cysteine proteinases (gingipains) from Porphyromonas gingivalis leading to lipopolysaccharide hyporesponsiveness J Immunol 2000; 165:411-418
37. Duncan L, Yoshioka M, Chandad F et al. Loss of lipopolysaccharide receptor CD14 from the surface of human macrophage-like cells mediated by Porphyromonas gingivalis outer membrane vesicles. Microb Pathog 2004; 36:319-325
38. Kim JI, Lee CJ, Jin MS et al. Crystal structure of CD14 and its implications for lipopolysaccharide signaling. J Biol Chem 2005; 280:11347-11351
39. Tada H, Sugawara S, Nemoto E et al. Proteolysis of CD14 on human gingival fibroblasts by arginine-specific cysteine proteinases from Porphyromonas gingivalis leading to down-regulation of lipopolysaccharide-induced interleukin-8 production. Infect Immun 2002; 70:3304-3307
40. Imamura T. The role of gingipains in the pathogenesis ofperiodontal disease. J Periodontol. 2003; 74:111-8
41. Lowther J, Robinson MW, Donnelly SM et al. The importance of pH in regulating the function of the Fasciola hepatica cathepsin L1 cysteine protease. PLoS Negl Trop Dis 2009; 3:e369
42. Stack CM, Donnelly S, Lowther J et al. The major secreted cathepsin L1 protease ofthe liver fluke, Fasciola hepatica: a Leu-12 to Pro-12 replacement in the nonconserved C-terminal region of the prosegment prevents complete enzyme autoactivation and allows definition of the molecular events in prosegment removal. J Biol Chem 2007; 282:16532-16543
43. Ferrero E, Hsieh CL, Francke U et al. CD14 is a member of the family of leucine-rich proteins and is encoded by a gene syntenic with multiple receptor genes. J Immunol 1990; 145:331-336
44. Ranjith-Kumar CT, Miller W, Xiong J et al. Biochemical and Functional Analyses of the Human Toll-like Receptor 3 Ectodomain. J Biol Chem 2007; 282:7668-7678
45. Kanaji S, Tanaka Y, Sakata Y et al. Squamous cell carcinoma antigen 1 is an inhibitor of parasite-derived cysteine proteases. FEBS Lett 2007; 581:4260-4264
46. Kopitar-Jerala N. The role of cystatins in cells of the immune system. FEBS Lett 2006; 580:295-301
47. Kane CM, Cervi L, Sun J et al. Helminth antigens modulate TLR-initiated dendritic cell activation. J Immunol 2004; 173:7454-7461
48. van Liempt E, van Vliet SJ, Engering A et al. Schistosoma mansoni soluble egg antigens are internalized by human dendritic cells through multiple C-type lectins and suppress TLR-induced dendritic cell activation. Mol Immunol 2007; 44:2605-2615
49. Alexander J, Satoskar AR, Russell DG. Leishmania species: models of intracellular parasitism. J Cell Sci 1999; 112:2993-2998
50. Reiner SL, Zheng S, WangAE et al. Leishmania promastigotes evade interleukin-12 (IL-12) induction by macrophages and stimulate a broad range of cytokines from CD4+ T-cells during initiation of infection. J Exp Med 1994; 179:447-252
51. Carrera L, Gazzinelli RT, Badolato R et al. Leishmania promastigotes selectively inhibit interleukin-12 induction in bone marrow-derived macrophages from susceptible and resistant mice. J Exp Med 1996; 183:515-520
52. Heinzel FP, Schoenhaut DS, Rerko RM et al. Recombinant interleukin 12 cures mice infected with Leishmania major. J Exp Med 1993; 177:1505-1510
53. Sypek JP,Chung CL, Mayor SHE et al. Resolution of cutaneous leishmaniasis: interleukin-12 initiates a protective T helper type 1 immune response. J Exp Med 1993; 177:1797-1802
54. Afonso LCC, Scharton TM, Vieira, LQ et al. The adjuvant effect of interleukin-12 in a vaccine against Leishmania major. Science 1994; 263:235-240
55. Buxbaum LU, Hubert D, Coombs GH et al. CPB cysteine proteases of Leishmania mexicana inhibit host Th1 responses and protective immunity. J Immunol 2003; 171:3711-3718
56. Cameron P, McGachy A, Anderson M et al. Inhibition of lipopolysaccharide-induced macrophage IL-12 production by Leishmania mexicana amastigotes: the role of cysteine peptidases and the NF-kappaB signaling pathway. J Immunol 2004; 173:3297-3304
57. Shapira S, Harb OS, Margarit J et al. Initiation and termination of NF-kappaB signaling by the intracellular protozoan parasite Toxoplasma gondii. J Cell Sci 2005; 118:3501-3508
58. Roiko MS, Carruthers VB. New roles for perforins and proteases in apicomplexan egress. Cell Microbiol 2009; 11:1444-1452
59. Nijman SM, Luna-Vargas MP, Velds A. A genomic and functional inventory of deubiquitinating enzymes. Cell 2005; 123:773-786
60. Levy DE, Garcia-Sastre A. The virus battles: IFN induction of the antiviral state and mechanisms of viral evasion. Cytokine Growth Factor Rev 2001; 12:143-156
61. Barretto N, Jukneliene D, Ratia K et al. The Papain like protease of severe acute respiratory syndrome coronavirus has deubiquitinating activity, J Virol 2005; 79:15189-15198
62. Ratia K, Pegan S, Takayama J et al. A noncovalent class of papain-like protease/deubiquitinase inhibitors blocks SARS virus replication. Proc Natl Acad Sci USA 2008; 105:16119-16124
63. Frieman M, Ratia K, Johnston RE et al. Severe acute respiratory syndrome coronavirus papain-like protease ubiquitin-like domain and catalytic domain regulate antagonism of IRF3 and NF-kappaB signaling. J Virol 2009; 83:6689-6705
64. Frieman M, Heise M, Baric R. SARS coronavirus and innate immunity. Virus Res 2007; 133:101-112
65. Zhou H, Perlman S. Mouse hepatitis virus does not induce Beta interferon synthesis and does not inhibit its induction by doublestranded RNA. J Virol 2007; 81:568-574
66. Versteeg GA, Bredenbeek PJ, van den Worm SH et al. Group 2 coronaviruses prevent immediate early interferon induction by protection of viral RNA from host cell recognition. Virology 2007; 361:18-26
67. Hengel H, Koszinowski UH, Conzelmann KK. Viruses know it all: new insights into IFN networks. Trends Immunol 2005; 26:396-401
68. Kattenhorn LM, Korbel GA, Kessler BM et al. A deubiquitinating enzyme encoded by HSV-1 belongs to a family ofcysteine proteases that is conserved across the family Herpesviridae. Mol. Cell 2005; 19:547-557
69. Schlieker C, Korbel GA, Kattenhorn LM et al. A deubiquitinating activity is conserved in the large tegument protein of the Herpesviridae. J Virol 2005; 79:15582-15585
70. Wang J, Loveland AN, Kattenhorn LM et al. High-molecular-weight protein (pUL48) of human cytomegalovirus is a competent deubiquitinating protease: mutant viruses altered in its activesite cysteine or histidine are viable. J Virol 2006; 80:6003-6012
71. Balakirev MY, Jaquinod M, Haas AL et al. Deubiquitinating function of adenovirus proteinase. J Virol 2002; 76:6323-6331
72. Barretto N, Jukneliene D, Ratia K et al. The papain-like protease of severe acute respiratory syndrome coronavirus has deubiquitinating activity. J Virol 2005; 79:15189-15198
73. Sweet CR, Conlon J, Golenbock DT et al. YopJ targets TRAF proteins to inhibit TLR-mediated NF-kappaB, MAPK and IRF3 signal transduction. Cell Microbiol 2007; 9:2700-2715
74. Zhou H, Monack DM, Kayagaki N et al. Yersinia virulence factor YopJ acts as a deubiquitinase to inhibit NF-kappa B activation. J Exp Med 2005; 202:1327-1332
75. Orth K, Xu Z, Mudgett MB et al. Disruption of signaling by Yersinia effector YopJ, a ubiquitin-like protein protease. Science 2000; 290:1594-1597
76. Ye Z, Petrof EO, Boone D et al. Salmonella effector AvrA regulation of colonic epithelial cell inflammation by deubiquitination, Am J Pathol 2007; 171:882-892
77. Misaghi S, Balsara ZR, Catic A et al. Chlamydia trachomatis-derived deubiquitinating enzymes in mammalian cells during infection. Mol Microbiol 2006; 61:142-150
78. Catic A, Misaghi A, Korbel GA et al. ElaD, a deubiquitinating protease expressed by E. coli. PLoS ONE 2007; 2:e381
79. Ponder EL, Bogyo M. Ubiquitin-like modifiers and their deconjugating enzymes in medically important parasitic protozoa, Eukaryot. Cell 2007; 6:1943-1952
80. Artavanis-Tsakonas K, Misaghi S, Comeaux CA et al. Identification by functional proteomics of a deubiquitinating/deNeddylating enzyme in Plasmodium falciparum. Mol Microbiol 2006; 61:1187-1195
81. Frickel EM, Quesada V, Muething L et al. Apicomplexan UCHL3 retains dual specificity for ubiquitin and Nedd8 throughout evolution. Cell Microbiol 2007; 9:1601-1610
82. Kostura MJ, Tocci MJ, Limjuco G et al. Identification of a monocyte specific pre-interleukin 1 beta convertase activity. Proc Natl Acad Sci USA 1989; 86:5227-5231
83. Black RA, Kronheim SR, Merriam JE et al. A pre-aspartate-specific protease from human leukocytes that cleaves pro-interleukin-1 beta. J Biol Chem 1989; 264:5323-5326
84. Kapur V, Majesky MW, Li LL et al Cleavage of interleukin 1 beta (IL-1 beta) precursor to produce active IL-1 beta by a conserved extracellular cysteine protease from Streptococcus pyogenes.Proc Natl Acad Sci USA 1993; 90:7676-7680
85. Zhang Z, Wang L, Seydel KB et al. Entamoeba histolytica cysteine proteinases with interleukin-1 beta converting enzyme (ICE) activity cause intestinal inflammation and tissue damage in amoebiasis. Mol Microbiol 2000; 37:542-548
86. Que X, Kim SH, Sajid M et al. A surface amebic cysteine proteinase inactivates interleukin-18. Infect Immun 2003; 71:1274-80
87. Kim SH, Azam T, Novick D et al. Identification of amino acid residues critical for biological activity in human interleukin-18. J Biol Chem 2002; 277:10998-11003
88. Wolf M, Albrecht S, Marki C. Proteolytic processing of chemokines: implications in physiological and pathological conditions. Int J Biochem Cell Biol 2008; 40:1185-1198
89. Dean RA, Cox JH, Bellac CL et al. Macrophage-specific metalloelastase (MMP-12) truncates and inactivates ELR+ CXC chemokines and generates CCL2, 7, 8 and 13 antagonists: potential role of the macrophage in terminating PMN influx. Blood 2008;112:3455-3464
90. Mikolajczyk-Pawlinska J, Travis J, Potempa J. Modulation of interleukin-8 activity by gingipains from Porphyromonas gingivalis: implications for pathogenicity of periodontal disease. FEBS Lett 1998; 440:282-286
91. O'Neill SM, Parkinson M, Strauss W et al. Immunodiagnosis of Fasciola hepatica infection (fascioliasis) in a human population in the Bolivian Altiplano using purified cathepsin L cysteine proteinase. Am J Trop Med Hyg 1998; 58:417-423
92. Duffus WP, Thorne K, Oliver R. Killing of juvenile Fasciola hepatica by purified bovine eosinophil proteins. Clin Exp Immunol 1980; 40:336-344
93. Duffus WP, Franks D. In vitro effect of immune serum and bovine granulocytes on juvenile Fasciola hepatica. Clin Exp Immunol 1980; 41:430-440
94. Carmona C, Dowd AJ, Smith AM et al. Cathepsin L proteinase secreted by Fasciola hepatica in vitro prevents antibody-mediated eosinophil attachment to newly excysted juveniles. Mol Biochem Parasitol 1993; 62:9-17
95. Berasain P, Carmona C, Frangione B et al. Fasciola hepatica: parasite-secreted proteinases degrade all human IgG subclasses: determination of the specific cleavage sites and identification of the immunoglobulin fragments produced. Exp Parasitol 2000; 94:99-110
96. Chung YB, Yang HJ, Kang SY et al. Activities of different cysteine proteases of Paragonimus westermani in cleaving human IgG. Korean J Parasitol 1997; 35:139-142
97. Kong Y, Chung YB, Cho SY et al. Cleavage of immunoglobulin G by excretory-secretory cathepsin S-like protease of Spirometra mansoni plerocercoid. Parasitology 1994;109:611-621
98. Auriault C, Ouaissi MA, Torpier G et al. Proteolytic cleavage of IgG bound to the Fc receptor of Schistosoma mansoni schistosomula. Parasite Immunol 1981; 3:33-44
99. Shin MH, Kita H, Park HY et al. Cysteine protease secreted by Paragonimus westermani attenuates effector functions of human eosinophils stimulated with immunoglobulin. G Infect Immun 2001; 69:1599-1604
100. Berasain P, Carmona C, Frangione B et al. Specific cleavage sites on human IgG subclasses by cruzipain, the major cysteine proteinase from Trypanosoma cruzi. Mol Biochem Parasitol 2003; 130:23-29
101. Wenig K, Chatwell L, von Pawel-Rammingen U et al. Structure of the streptococcal endopeptidase IdeS, a cysteine proteinase with strict specificity for IgG. Proc Natl Acad Sci USA. 2004; 101: 17371-17376
102. von Pawel-Rammingen U, Johansson BP, Bjorck L. IdeS, a novel streptococcal cysteine proteinase with unique specificity for immunoglobulin. G EMBO J 2002; 21:1607-1615
103. von Pawel-Rammingen U, Bjorck L. IdeS and SpeB: immunoglobulin-degrading cysteine proteinases of Streptococcus pyogenes. Curr Opin Microbiol 2003; 6:50-55
104. Collin M, Olsen A. Effect of SpeB and EndoS from Streptococcus pyogenes on human immunoglobulins. Infect Immun 2001; 69:7187-7189
105. Plaut AG. The IgAl proteases of pathogenic bacteria. Annu Rev Microbiol 1983; 37:603-622
106. Kilian M, Mestecky J, Russell MW. Defense mechanisms involving Fc-dependent functions of immunoglobulin A and their subversion by bacterial immunoglobulin A proteases. Microbiol Rev 1988; 52:296-303
107. Mistry D, Stockley RA. IgA1 protease. Int J Biochem Cell Biol 2006; 8:1244-1248
108. Garcia-Nieto RM, RicoMata R, Arias-Negrete S et al. Degradation of human secretory IgA1 and IgA2 by Entamoeba histolytica surface-associated proteolytic activity. Parasitol Int 2008; 57:417-423
109. Que X, Reed SL. Cysteine proteinases and the pathogenesis of amebiasis. Clin Microbiol Rev 2000; 13:196-206
110. Kuo CF, Lin YS, Chuang WJ et al. Degradation of complement 3 by streptococcal pyrogenic exotoxin B inhibits complement activation and neutrophil opsonophagocytosis. Infect Immun 2008; 76:1163-1169
111. Terao Y, Mori Y, Yamaguchi M et al. Group A streptococcal cysteine protease degrades C3 (C3b) and contributes to evasion of innate immunity. J Biol Chem 2008; 283:6253-6260
112. Reed SL, Ember JA, Herdman DS et al. The extracellular neutral cysteine proteinase of Entamoeba histolytica degrades anaphylatoxins C3a and C5a. J Immunol 1995; 155:266-274
113. Popadiak K, Potempa J, Riesbeck K et al. Biphasic effect of gingipains from Porphyromonas gingivalis on the human complement system. J Immunol 2007; 178:7242-7250
114. Potempa M, Potempa J, Kantyka T et al. Interpain A, a cysteine proteinase from Prevotella intermedia, inhibits complement by degrading complement factor C3. PLoS Pathog 2009; 5:e1000316
115. Lathem WW, Bergsbaken T, Welch RA. Potentiation of C1 esterase inhibitor by StcE, a metalloprotease secreted by Escherichia coli O157:H7. J Exp Med 2004; 199:1077-1087